Fox Run Management’s Pediatrix Medical MD Stock Holding History

Fox Run Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,783	Closed	-$345K	–	1071
2025 Q1	$345K	Buy	+23,783	New	+$338K	0.05%	628
2023 Q3	–	Sell	-15,584	Closed	-$221K	–	870
2023 Q2	$221K	Buy	+15,584	New	+$219K	0.06%	551
2021 Q3	–	Sell	-9,607	Closed	-$290K	–	565
2021 Q2	$290K	Buy	+9,607	New	+$284K	0.26%	173
2020 Q1	–	Sell	-11,379	Closed	-$316K	–	271
2019 Q4	$316K	Buy	+11,379	New	+$285K	0.25%	176
2019 Q2	–	Sell	-14,137	Closed	-$384K	–	547
2019 Q1	$384K	Sell	14,137 -246	-2%	-$8.25K	0.22%	181
2018 Q4	$475K	Sell	14,383 -2,252	-14%	-$90.5K	0.25%	125
2018 Q3	$776K	Buy	+16,635	New	+$764K	0.34%	39
2018 Q1	–	Sell	-12,060	Closed	-$644K	–	839
2017 Q4	$644K	Sell	12,060 -1,340	-10%	-$63.2K	0.19%	192
2017 Q3	$578K	Buy	+13,400	New	+$637K	0.16%	239

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fox Run Management's MD Position: Q2 2025 in Review

Fox Run Management sold out of Pediatrix Medical (MD) in Q2 2025, closing a stake of 23,783 shares — an estimated $345K sold.

Fox Run Management first reported a position in MD in Q3 2017 and held it in 9 quarters. The position peaked at $776K in Q3 2018. 264 funds tracked by Wall St. Rank hold MD as of Q2 2025.

Fox Run Management reported no remaining Pediatrix Medical position as of Q2 2025 after selling out during the quarter.
Fox Run Management sold 23,783 Pediatrix Medical shares in Q2 2025, an estimated $345K.
Fox Run Management first reported a position in Pediatrix Medical in Q3 2017 and held it in 9 quarters.
Fox Run Management's Pediatrix Medical position peaked at $776K in Q3 2018.
264 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2025.

Based on Fox Run Management's 13F filing for Q2 2025, filed 6 Aug 2025.